CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-20 | Foster-Cheek Kaye I Director | Grant or award · Stock options (right to buy) | +8,888 | 8,888 | ||
| 2021-05-20 | CLARK IAN T Director | Grant or award · Restricted stock unit | +1,585 | 1,585 | ||
| 2021-05-20 | CLARK IAN T Director | Grant or award · Stock options (right to buy) | +8,888 | 8,888 | ||
| 2021-05-20 | Clancy Paul J Director | Grant or award · Restricted stock unit | +1,585 | 1,585 | ||
| 2021-05-20 | Clancy Paul J Director | Grant or award · Stock options (right to buy) | +8,888 | 8,888 | ||
| 2021-05-20 | Ho Maykin Director | Grant or award · Restricted stock unit | +1,585 | 1,585 | ||
| 2021-05-20 | Ho Maykin Director | Grant or award · Stock options (right to buy) | +8,888 | 8,888 | ||
| 2021-05-14 | Miles Darrin Chief Commercial Officer | Sale | −3,462 | $55.41 | $192K | 7,209 |
| 2021-04-20 | Bowden Christopher Chief Medical Officer | Option exercise | +12,513 | $35.16 | $440K | 28,000 |
| 2021-04-20 | Bowden Christopher Chief Medical Officer | Option exercise | +1,888 | $39.76 | $75K | 29,888 |
| 2021-04-20 | Bowden Christopher Chief Medical Officer | Sale | −14,401 | $55.11 | $794K | 15,487 |
| 2021-04-20 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −12,513 | 0 | ||
| 2021-04-20 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −1,888 | 43,332 | ||
| 2021-04-19 | Bowden Christopher Chief Medical Officer | Option exercise | +3,210 | $35.16 | $113K | 18,697 |
| 2021-04-19 | Bowden Christopher Chief Medical Officer | Sale | −3,210 | $55.16 | $177K | 15,487 |
| 2021-04-19 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −3,210 | 12,513 | ||
| 2021-04-16 | Alenson Carman Principal Accounting Officer | Sale | −1,118 | $55.89 | $62K | 0 |
| 2021-04-15 | Alenson Carman Principal Accounting Officer | Sale | −991 | $54.00 | $54K | 1,118 |
| 2021-03-05 | Miles Darrin Chief Commercial Officer | Sale | −500 | $48.58 | $24K | 10,671 |
| 2021-03-01 | Miles Darrin Chief Commercial Officer | Sale | −2,200 | $47.99 | $106K | 11,171 |
Page 42 of 48 · 941 trades